ACUR - Acura Pharmaceuticals, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Jun 2017)Next Qtr. (Sep 2017)Current Year (2017)Next Year (2018)
No. of Analysts0000
Avg. Estimate0000
Low Estimate0000
High Estimate0000
Year Ago EPS-0.28-0.19N/AN/A
Revenue EstimateCurrent Qtr. (Jun 2017)Next Qtr. (Sep 2017)Current Year (2017)Next Year (2018)
No. of Analysts1111
Avg. Estimate92k360k1.4M31.7M
Low Estimate340k360k1.4M31.7M
High Estimate340k360k1.4M31.7M
Year Ago Sales257k218k4.46M1.4M
Sales Growth (year/est)-64.20%65.10%-68.60%2,164.30%
Earnings History6/29/20169/29/201612/30/20163/30/2017
EPS Est.-0.28-0.27-0.27-0.11
EPS Actual-0.28-0.190.130.03
Difference00.080.40.14
Surprise %0.00%29.60%148.10%127.30%
EPS TrendCurrent Qtr. (Jun 2017)Next Qtr. (Sep 2017)Current Year (2017)Next Year (2018)
Current Estimate0000
7 Days Ago-0.11-0.12-0.460.37
30 Days Ago-0.11-0.12-0.460.37
60 Days Ago-0.11-0.12-0.460.37
90 Days Ago-0.11-0.12-0.460.37
EPS RevisionsCurrent Qtr. (Jun 2017)Next Qtr. (Sep 2017)Current Year (2017)Next Year (2018)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Down Last 90 DaysN/AN/AN/AN/A
Growth EstimatesACURIndustrySectorS&P 500
Current Qtr.N/AN/AN/A0.16
Next Qtr.N/AN/AN/A0.27
Current YearN/AN/AN/A0.07
Next YearN/AN/AN/A0.12
Next 5 Years (per annum)N/AN/AN/A0.10
Past 5 Years (per annum)58.88%N/AN/AN/A